Journal of Leukocyte Biology: An Official Publication of the Reticuloendothelial Society | |
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies | |
Drake, Charles G.1  | |
[1] Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA | |
关键词: castration‐; resistant prostate cancer; tumor microenvironment; immune infiltration; immunosuppression; tumor‐; associated macrophage; myeloid‐; derived suppressor cell; | |
学科分类:生理学 | |
来源: Federation of American Societies for Experimental Biology | |
【 摘 要 】
Prostate cancer is the second most common cause of cancer mortality in men in the United States. As is the case for other tumor types, accumulating evidence suggests an important role for myeloid-derived cells in the promotion and progression of prostate cancer. Here, we briefly describe myeloid-derived cells that interact with tumor cells and what is known about their immune suppressive function. We next discuss new evidence for tumor cell–mediated myeloid infiltration via the PI3K/PTEN/AKT signaling pathway and an alternative mechanism for immune evasion that may be regulated by an endoplasmic reticulum stress response. Finally, we discuss several interventions that target myeloid-derived cells to treat prostate cancer.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201902188888421ZK.pdf | 86KB | download |